Newsletter

Let Rare Mutations Speak: Novel Mechanisms in Immune System Regulation

Let Rare Mutations Speak: Novel Mechanisms in Immune System Regulation

Chris Overall lab investigated a unique mutation in the MALT1 gene, which lead to a patient that paradoxically had a poor response to infection and autoimmune symptoms.

Earl W. Davie Symposium 2015 – in Review

Earl W. Davie Symposium 2015 – in Review

To honor the illustrious career of Dr. Earl W. Davie, the CBR hosts the annual Earl Davie Symposium, showcasing endeavors in the fields of vascular biology, hemostasis-thrombosis, cardiovascular and neurologic disease, by both local and international experts. Read the full review of the day.

Dentist with a Lab Coat

Dentist with a Lab Coat

On a cold Monday morning, nearly a million health-care providers in Canada are going to see patients. A small number of them, less than one in 200, also work as a scientist. Dr. Hugh Kim of the Centre for Blood Research is one of the newest clinician-scientists in British Columbia.

Direct Oral Anticoagulants: CBR Researchers Join the Action

Direct Oral Anticoagulants: CBR Researchers Join the Action

While saving countless lives, conventional anticoagulants require frequent injections and regular doctor visits to monitor clotting parameters. However, treatment options are changing with the emergence of a new generation of anticoagulants – direct oral anticoagulants (DOACs).

CBR Research Day 2015: In Review

CBR Research Day 2015: In Review

The annual CBR Research Day is held to celebrate the end of the Summer Studentship Program, wherein undergraduates embarked on a research project under the expert guidance of the CBR members. This year, the day began with enthusiastic summer students gathering

Striking a balance between blood product quality and safety

Striking a balance between blood product quality and safety

Dr. Peter Schubert, a Research Associate and Manager of Dr. Dana Devine’s Laboratory at CBR, collaborated with an industry partner, TerumoBCT, to investigate the impact of pathogen inactivation technologies in whole blood, as opposed to standard practice of individual blood components.

Kelly McNagny joins CDRD as a new Co-Scientific Director

Kelly McNagny joins CDRD as a new Co-Scientific Director

“We are very fortunate to have Dr. McNagny join the organization. His deep experience and scientific expertise, particularly in the area of stem cell biology will allow us to bring added value to our stakeholders. We have collaborated with him on individual projects for several years, and now look forward to having him take on this expanded role as a part of our Executive Team.”

Taming antimicrobial peptides for treating bacterial infections

Taming antimicrobial peptides for treating bacterial infections

A toxic antimicrobial compound secreted by an Australian growling grass frog, Litoria raniformis, can prove useful against antibiotic resistant bacteria. The Kizhakkedathu group at CBR undertook this quest in their recent paper published in Biomacromolecules.

Where Will Your Graduate Education Take You?

Where Will Your Graduate Education Take You?

Many students choose to enter graduate school because they enjoy research and are passionate about science, but few have a concrete idea of the type of career they would like following graduation.